Filter By Industry
Filter By Tag


Biomed Industries Press releases

1 - 3 of 3 Press Releases

Mar 11, 2024
Biomed Industries, Inc. (Biomed), a leading biopharmaceutical company, announced its latest breakthrough in obesity treatment with the development of NA-931, a triple receptor agonist targeting IGF-1, GLP-1, and GIP hormones.

Mar 04, 2024
Biomed Industries, Inc. (Biomed), a leading bio-pharmaceutical company, is set to present three significant papers at the AD/PD™ 2024 International Conference on Alzheimer's and Parkinson's Diseases, taking place in Lisbon, Portugal, from March 5th to...

Feb 02, 2024
Biomed Industries, Inc. (Biomed) announced today that it has developed a promising obesity drug, NA-921, which is poised for Phase 2/3 clinical trials. NA-921 is a small molecule drug available in oral formulation.

Biomed Industries RSS Feed